{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T16:15:23Z","timestamp":1787933723125,"version":"build-2784847793"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100013116","name":"Merz Pharmaceuticals","doi-asserted-by":"crossref","award":["IIT-1885"],"award-info":[{"award-number":["IIT-1885"]}],"id":[{"id":"10.13039\/501100013116","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","prd-journal.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism & Related Disorders"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.parkreldis.2018.06.019","type":"journal-article","created":{"date-parts":[[2018,6,12]],"date-time":"2018-06-12T11:47:24Z","timestamp":1528804044000},"page":"65-69","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["Botulinum toxin in essential hand tremor - A randomized double-blind placebo-controlled study with customized injection approach"],"prefix":"10.1016","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2138-1108","authenticated-orcid":false,"given":"Shivam Om","family":"Mittal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duarte","family":"Machado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divyanshu","family":"Dubey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahman","family":"Jabbari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2018.06.019_bib1","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/mds.22838","article-title":"How common is the most common adult movement disorder? Update on the worldwide prevalence of essential tremor","volume":"25","author":"Louis","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2018.06.019_bib2","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.781","article-title":"Depression and social phobia in essential tremor and Parkinson's disease","volume":"7","author":"Smeltere","year":"2017","journal-title":"Brain Behav."},{"key":"10.1016\/j.parkreldis.2018.06.019_bib3","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.parkreldis.2015.04.019","article-title":"Tremor-related quality of life: a comparison of essential tremor vs. Parkinson's disease patients","volume":"21","author":"Louis","year":"2015","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2018.06.019_bib4","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/ncpneuro0347","article-title":"Essential tremor: emerging views of a common disorder","volume":"2","author":"Benito-Le\u00f3n","year":"2006","journal-title":"Nat. Clin. Pract. Neurol."},{"key":"10.1016\/j.parkreldis.2018.06.019_bib5","doi-asserted-by":"crossref","unstructured":"M.K. Lyons, Deep brain stimulation: current and future clinical applications, Mayo Clin. Proc. 86 (n.d.) 662\u2013672. doi:10.4065\/mcp.2011.0045.","DOI":"10.4065\/mcp.2011.0045"},{"key":"10.1016\/j.parkreldis.2018.06.019_bib6","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1136\/jnnp.2007.118786","article-title":"Cognitive declines following bilateral subthalamic nucleus deep brain stimulation for the treatment of Parkinson's disease","volume":"79","author":"York","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.parkreldis.2018.06.019_bib7","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jns.2011.05.041","article-title":"Efficacy and safety of incobotulinumtoxinA (NT 201, XEOMIN(R), botulinum neurotoxin type A, without accessory proteins) in patients with cervical dystonia","volume":"308","author":"Comella","year":"2011","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.parkreldis.2018.06.019_bib8","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1111\/j.1526-4637.2011.01245.x","article-title":"Treatment of refractory pain with botulinum toxins\u2013an evidence-based review","volume":"12","author":"Jabbari","year":"2011","journal-title":"Pain Med."},{"key":"10.1016\/j.parkreldis.2018.06.019_bib9","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1212\/WNL.56.11.1523","article-title":"A randomized, double masked, controlled trial of botulinum toxin type A in essential hand tremor","volume":"56","author":"Brin","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2018.06.019_bib10","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/mds.870110306","article-title":"A randomized, double-blind, placebo-controlled study to evaluate botulinum toxin type A in essential hand tremor","volume":"11","author":"Jankovic","year":"1996","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2018.06.019_bib11","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.mayocp.2017.06.010","article-title":"Botulinum toxin in Parkinson disease tremor: a randomized, double-blind, placebo-controlled study with a customized injection approach","volume":"92","author":"Mittal","year":"2017","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.parkreldis.2018.06.019_bib12","series-title":"Park. Dis. Mov. Disord. 2nd Ed. Balt","first-page":"225","article-title":"Clinical rating scale for tremor","author":"Fahn","year":"1993"},{"key":"10.1016\/j.parkreldis.2018.06.019_bib13","doi-asserted-by":"crossref","DOI":"10.5334\/tohm.116","article-title":"Methodological issues in clinical drug development for essential tremor","volume":"2","author":"Carranza","year":"2012","journal-title":"Tremor and Other Hyperkinetic Movements"}],"container-title":["Parkinsonism & Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802018302785?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802018302785?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T07:03:06Z","timestamp":1604386986000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802018302785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":13,"alternative-id":["S1353802018302785"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2018.06.019","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.733495611.793549330","asserted-by":"object"}]},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Botulinum toxin in essential hand tremor - A randomized double-blind placebo-controlled study with customized injection approach","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2018.06.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}